Risk Assessment of PSA Recurrent Prostate Cancer
Listen now
Description
As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]
More Episodes
As part of the 2024 Developmental Disabilities Conference, Dr. Ellen Elias is a pediatrician and geneticist who has dedicated her career to the care of children and youth with medical complexity and developmental disabilities. She discusses sexuality and the need for education, normalization and...
Published 06/12/24
As part of the 2024 Developmental Disabilities Conference, Elizabeth Vosseller and Ian Nordling demonstrate techniques for helping autistic people who cannot use speech reliably to communicate. They discuss the neuroscience behind techniques for helping people with sensory and movement...
Published 06/12/24
Published 06/12/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
